CARAZOLOL HYDROCHLORIDE, (S)-

Cl.CC(C)NC[C@H](O)COC1=CC=CC2=C1C3=C(N2)C=CC=C3

InChIKey=DXYNUICMBSWZMR-ZOWNYOTGSA-N

InChI=1S/C18H22N2O2.ClH/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16;/h3-9,12-13,19-21H,10-11H2,1-2H3;1H/t13-;/m0./s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography.	2006-10-20	16784906

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:38:46 GMT 2025` Edited by `admin` on `Mon Mar 31 23:38:46 GMT 2025`
Record UNII	9P0YF51U8J
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

2-PROPANOL, 1-(9H-CARBAZOL-4-YLOXY)-3-((1-METHYLETHYL)AMINO)-, HYDROCHLORIDE (1:1), (S)-

Preferred Name

English

CARAZOLOL HYDROCHLORIDE, (S)-

Common Name

English

Code System Code Type Description

PUBCHEM

70394231

Created by admin on Mon Mar 31 23:38:46 GMT 2025 , Edited by admin on Mon Mar 31 23:38:46 GMT 2025

PRIMARY

FDA UNII

9P0YF51U8J

Created by admin on Mon Mar 31 23:38:46 GMT 2025 , Edited by admin on Mon Mar 31 23:38:46 GMT 2025

PRIMARY

Related Record Type Details


					4IVL5T473E

RACEMATE -> ENANTIOMER